The $200 million Series D investment gives the smart ring maker a valuation of $5.2 billion. The past year has been an active one for Ōura. It acquired Sparta Science and Veri, launched its Gen 4 ring ...

But 2024 was a relatively quiet year for smartwatches, during which iterative updates reigned supreme. That happens in a ...

Smart ring maker Oura announced on Thursday that it has closed a $200 million Series D funding round, bringing the company’s ...

Dexcom’s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.

URA, the company behind Oura Ring, the world’s leading smart ring, today announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the ...

Fidelity Management led Ōura’s latest round alongside US-based glucose-monitoring group Dexcom, taking its total capital ...

Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its glucose ...

DexCom Inc. DXCM recently announced the launch of a proprietary Generative AI (GenAI) platform, making Dexcom the first ...

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

You could buy everything from compression socks to a treadmill with any extra funds, but there are some hoops to jump through ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

My first cat died mysteriously at age seven, her white-blood-cell count dangerously elevated, just two days after I noticed ...